Publication |
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism. Medler J, Kucka K, Melo V, Zhang T, von Rotenhan S, Ulrich J, Bremer E, Hudecek M, Beilhack A, Wajant H. Theranostics. 2022 Jan 1;12(4):1486-1499. doi: 10.7150/thno.66119. eCollection 2022.
|
Membrane lymphotoxin-α2β is a novel tumor necrosis factor (TNF) receptor 2 (TNFR2) agonist. Kucka K, Lang I, Zhang T, Siegmund D, Medler J, Wajant H. Cell Death Dis. 2021 Apr 6;12(4):360. doi: 10.1038/s41419-021-03633-8.
|
|
| Last update Publications 26.02.2022 |
|